Related Experiment Video
Updated: Jun 9, 2025
09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.4K
The urgent need for clear and concise regulations on exosome-based interventions
Misao Fujita1, Taichi Hatta2, Tsunakuni Ikka3
1Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application (CiRA), Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; Institute for the Advanced Study of Human Biology (WPI-ASHBi), KUIAS, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Stem Cell Reports
|October 25, 2024
Summary
Countries need clear regulations for stem cells and regenerative medicine. Failure to regulate risks patient safety, as seen in concerning international cases.
Area of Science:
- Regenerative Medicine
- Biotechnology Regulation
- Public Health Policy
Background:
- The rapid advancement of regenerative medicine, including stem cell and exosome therapies, outpaces current regulatory frameworks globally.
- Unclear or absent regulations create a fertile ground for unproven and potentially unsafe treatments to proliferate.
- Patient safety is paramount in the development and application of novel medical interventions.
Related Concept Videos
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
02:24Regulation of Expression Occurs at Multiple Steps
3.0K
3.0K